EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Evolving MS criteria and the interpretation of research

Afsaneh Shirani iD, Benjamin M Segal, Olaf Stuve iD

Therapeutic Advances in Neurological Disorders · 2026-08 · 19

DOI: 10.1177/17562864261471995 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Therapeutic Advances in Neurological Disorders, online erschienen am 06.08.2026. Verfasst von Afsaneh Shirani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Saint Luke's Marion Bloch Neuroscience Institute, University of Missouri-Kansas City, Kansas City, MO, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

recognized consequences, including diagnostic heterogeneity across generations of datasets that could affect future bio-marker discovery and artificial intelligence (AI)-driven disease modeling.

Schlagwörter

Stichwörter der Autor:innen

McDonald criteriabiomarkersclinical trialsdiagnostic criteriadisease classificationexternal validityhistorical cohortsmisclassification biasmultiple sclerosisresearch methodology

Autor:innen und Institutionen

  • Department of Neurology, Saint Luke's Marion Bloch Neuroscience Institute, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Department of Neurology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Neuroscience Research Institute, The Ohio State University Medical Center, Columbus, OH, USA.
  • Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9096, USA.
  • Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • VA North Texas Health Care System, Dallas, TX, USA.

ORCID-Profile: Afsaneh Shirani, Olaf Stuve

Zitieren

APA

Shirani, A., Segal, B. M., & Stuve, O. (2026). Evolving MS criteria and the interpretation of research. Therapeutic Advances in Neurological Disorders, 19. https://doi.org/10.1177/17562864261471995

Vancouver

Shirani A, Segal BM, Stuve O. Evolving MS criteria and the interpretation of research. Therapeutic Advances in Neurological Disorders. 2026;19. doi:10.1177/17562864261471995

BibTeX
@article{Shirani2026,
  author = {Shirani, Afsaneh and Segal, Benjamin M and Stuve, Olaf},
  title = {Evolving MS criteria and the interpretation of research},
  journal = {Therapeutic Advances in Neurological Disorders},
  year = {2026},
  volume = {19},
  doi = {10.1177/17562864261471995}
}
Kostenlos starten →